1. Home
  2. CPIX vs SLNG Comparison

CPIX vs SLNG Comparison

Compare CPIX & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • SLNG
  • Stock Information
  • Founded
  • CPIX 1999
  • SLNG 2013
  • Country
  • CPIX United States
  • SLNG United States
  • Employees
  • CPIX N/A
  • SLNG N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • CPIX Health Care
  • SLNG Utilities
  • Exchange
  • CPIX Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • CPIX 68.7M
  • SLNG 81.1M
  • IPO Year
  • CPIX 2009
  • SLNG N/A
  • Fundamental
  • Price
  • CPIX $4.70
  • SLNG $5.40
  • Analyst Decision
  • CPIX
  • SLNG Strong Buy
  • Analyst Count
  • CPIX 0
  • SLNG 1
  • Target Price
  • CPIX N/A
  • SLNG $12.00
  • AVG Volume (30 Days)
  • CPIX 21.7K
  • SLNG 19.8K
  • Earning Date
  • CPIX 05-06-2025
  • SLNG 05-07-2025
  • Dividend Yield
  • CPIX N/A
  • SLNG N/A
  • EPS Growth
  • CPIX N/A
  • SLNG 201.19
  • EPS
  • CPIX N/A
  • SLNG 0.08
  • Revenue
  • CPIX $41,083,299.00
  • SLNG $70,861,000.00
  • Revenue This Year
  • CPIX N/A
  • SLNG $8.97
  • Revenue Next Year
  • CPIX N/A
  • SLNG $6.90
  • P/E Ratio
  • CPIX N/A
  • SLNG $66.89
  • Revenue Growth
  • CPIX 5.82
  • SLNG 7.30
  • 52 Week Low
  • CPIX $1.04
  • SLNG $3.71
  • 52 Week High
  • CPIX $7.25
  • SLNG $8.28
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 52.45
  • SLNG 50.91
  • Support Level
  • CPIX $4.32
  • SLNG $5.24
  • Resistance Level
  • CPIX $4.86
  • SLNG $6.00
  • Average True Range (ATR)
  • CPIX 0.34
  • SLNG 0.38
  • MACD
  • CPIX -0.02
  • SLNG 0.04
  • Stochastic Oscillator
  • CPIX 36.89
  • SLNG 60.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: